David Badawi - 16 Jan 2026 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Role
Chief Technology Officer, Director
Signature
/s/Jeremy Hayden, Attorney-in-Fact for David Badawi
Issuer symbol
SGHT
Transactions as of
16 Jan 2026
Net transactions value
-$32,014
Form type
4
Filing time
21 Jan 2026, 16:56:38 UTC
Previous filing
06 Jan 2026
Next filing
05 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Badawi David Chief Technology Officer, Director C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK /s/Jeremy Hayden, Attorney-in-Fact for David Badawi 21 Jan 2026 0001870825

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGHT Common Stock Sale $32,014 -4,836 -0.25% $6.62 1,912,273 16 Jan 2026 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Reflects shares of the Issuer's common stock, par value $0.001 per share ("common stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units.
F2 Reflects the weighted average price at which the shares of common stock were sold. The shares were sold in multiple transactions at prices ranging from $6.44 to $6.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 Includes (i) 1,774,250 shares of common stock, and (ii) 138,023 shares of common stock which shall be acquired upon the vesting and settlement of restricted stock units ("RSUs") that have not yet vested.